May Wang
Corporate Officer/Principal en HUTCHMED (CHINA) LIMITED .
Cargos activos de May Wang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HUTCHMED (CHINA) LIMITED | Corporate Officer/Principal | 01/01/2010 | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 27/07/2011 | - |
Historial de carrera de May Wang
Antiguos cargos conocidos de May Wang.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Formación de May Wang.
| Purdue University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| China | 2 |
| Hong-Kong | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- May Wang
- Experiencia
